Basic Attention Token (BATBTC) looks more and more ready to grow... Let's take a look at some bullish signals on this chart.
1) The trading volume is going really high.
2) We have a higher low compared to 9-May.
3) Very strong RSI indicator.
4) Prices trading above EMA300 and MA200.
5) BATBTC above the cloud.
All these signals are bullish.
A higher-high is possible next.
My target is marked with a magenta dashed line... This is short-term, mid/long-term so much more is possible.
This is not financial advice.
Namaste.
1) The trading volume is going really high.
2) We have a higher low compared to 9-May.
3) Very strong RSI indicator.
4) Prices trading above EMA300 and MA200.
5) BATBTC above the cloud.
All these signals are bullish.
A higher-high is possible next.
My target is marked with a magenta dashed line... This is short-term, mid/long-term so much more is possible.
This is not financial advice.
Namaste.
Note
A higher-high has been hit.🚨 TOP FREE Trades
ETH +1450% · AAVE +1134%
XRP +749% · DOGS +868%
BTC +563% · SOL +658%
t.me/anandatrades/1350
🚨 FREE Analyses & New Results
t.me/masteranandatrades/6499
🚨 PREMIUM LIFETIME (Since 2017)
lamatrades.com
ETH +1450% · AAVE +1134%
XRP +749% · DOGS +868%
BTC +563% · SOL +658%
t.me/anandatrades/1350
🚨 FREE Analyses & New Results
t.me/masteranandatrades/6499
🚨 PREMIUM LIFETIME (Since 2017)
lamatrades.com
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
🚨 TOP FREE Trades
ETH +1450% · AAVE +1134%
XRP +749% · DOGS +868%
BTC +563% · SOL +658%
t.me/anandatrades/1350
🚨 FREE Analyses & New Results
t.me/masteranandatrades/6499
🚨 PREMIUM LIFETIME (Since 2017)
lamatrades.com
ETH +1450% · AAVE +1134%
XRP +749% · DOGS +868%
BTC +563% · SOL +658%
t.me/anandatrades/1350
🚨 FREE Analyses & New Results
t.me/masteranandatrades/6499
🚨 PREMIUM LIFETIME (Since 2017)
lamatrades.com
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.